乳房組織生検装置の世界市場規模・シェア・開発・成長・需要予測

【英語タイトル】Breast Biopsy Devices Market by Product (Guidance Systems, Biopsy Needles/Guns, Biopsy Tables, Biopsy Wires), by Procedure Type (Vacuum-Assisted, Core Needle, Fine Needle Aspiration, Surgical), by Imaging Modality (Mammography Guided Stereotactic, Ultrasound, MRI, CT), by End-User (Diagnostic Centers, Hospitals), by Geography (U.S., Canada, Germany, France, U.K., Italy, Spain, Japan, China, India, Australia, Brazil, Mexico) - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023

P&S Market Researchが出版した調査資料(PSM804029)・商品コード:PSM804029
・発行会社(調査会社):P&S Market Research
・発行日:2018年2月
・ページ数:143
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,100 ⇒換算¥550,800見積依頼/購入/質問フォーム
Group License(5名様閲覧用)USD6,100 ⇒換算¥658,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,100 ⇒換算¥982,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

The growth is mainly led by product and technological innovations, increasing incidence of breast cancer cases, rising propensity for minimally invasive surgeries, and mounting number of breast cancer screening programs.
Insights on market segments

On the basis of the procedure conducted for breast biopsy, the market is categorized into vacuum-assisted, core needle, fine needle aspiration, and surgical biopsy. Vacuum-assisted biopsies have been accounting for the largest share in the breast biopsy devices market till now. It is also expected to be the fastest growing category during the forecast period. This can be mainly attributed to its various advantages, such as its ability to precisely locate the area of abnormality using imaging guidance, so that samples are removed only from the region of interest.

On the basis of product, the breast biopsy devices market has been segmented into guidance systems, biopsy needles/guns, biopsy tables, biopsy wires, and other products. Guidance systems are estimated to hold the largest share of 40.1%, in the market in 2017, with its demand majorly driven by the availability of stereotactic breast biopsy and tomosynthesis options in a single system, and the requirement of these systems in all types of surgeries.

Different types of imaging modalities are used while performing breast biopsy procedure, such as mammography guided stereotactic biopsy, ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), and several others. Among these, Mammography guided stereotactic biopsy has been holding the largest share in the breast biopsy devices market till now, as it is a minimally invasive procedure and the needle used does not distort the breast tissue. However, ultrasound guided biopsy is expected to be the fastest growing imaging modality during the forecast period.

Hospitals, diagnostic centers, and other healthcare providers constitute the end-user base in the breast biopsy devices market. Diagnostic centers have been the largest end user in the breast biopsy devices market till now. However, as hospitals are witnessing increasing demand for advanced healthcare facilities and growing healthcare infrastructure, the category is expected to be the fastest growing end-user during the forecast period.

APAC to be the fastest growing market for breast biopsy devices

During the forecast period, the breast biopsy devices industry is expected to witness the fastest growth in in Asia-Pacific (APAC), owing to growing geriatric population, increasing prevalence of breast cancer, growing awareness about breast cancer, rising healthcare expenditure, per capita income, and increasing research in breast biopsy devices in the region. According to National Institute of Cancer Prevention and Research, breast cancer is the most common cancer in women in India and accounts for about a quarter of all cancers in women in Indian cities, and the average age for breast cancer in India is almost a decade lower than that in the West.

According to International Agency for Research on Cancer, in 2012, breast cancer incidences reported in India were 144,937 and the mortality rate in women in India was 70,218, which is comparatively higher than China (47,989). In order to balance these statistics, the government and several other organizations are also creating awareness about breast cancer. For instance, October has been designated as the breast cancer awareness month by the government of India, which is an annual campaign to educate people about breast cancer. Also, the Pink Initiative, a registered charity in Mumbai, creates awareness about breast cancer amongst women in India. These factors cumulatively lead to growth in the demand of breast biopsy devices in the region.

Breast biopsy surgeries are cheaper in India and they are also witnessing an increase in the research and development for the treatment of breast cancer, which is ultimately propelling the growth of the breast biopsy devices market in the region. For instance, a team of researchers from Tohoku University, in January 2016, developed a new method to detect breast cancer by combining a mammogram with an ultrasound in a procedure that appears to be more accurate than mammogram testing alone.

Key players launching new products for market expansion

Globally, key players in the breast biopsy devices industry are launching products to gain a larger market share. For instance, in November 2017, Siemens Healthineers, a subsidiary of Siemens AG, unveiled its new Mammomat Revelation imaging system at the 2017 Radiological Society of North America (RSNA) Annual Meeting in Chicago. 3D HD Breast Biopsy uses company’s 50-degree wide-angle HD breast tomosynthesis to obtain more targeted, accurate biopsies at a lower dose. The system also offers titanium contrast-enhanced mammography exams and automated breast density measurement.

In August 2017, Hologic Inc. announced the commercial availability of Brevera breast biopsy system with CorLumina imaging technology, in the U.S. The Brevera system provides clinicians with more information at the point of care and results in significant cost and time savings without compromising with accuracy or patient health outcomes.

Some of the other major players operating in the breast biopsy devices market include Danaher Corporation, Argon Medical Devices Inc., Becton, Dickinson and Company, Sterylab S.R.L., Scion Medical Technologies LLC, Planmed Oy, Medtronic plc, and Cook Medical LLC.

【レポートの目次】

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Product

1.3.2 Market Segmentation by Procedure Type

1.3.3 Market Segmentation by Imaging Modality

1.3.4 Market Segmentation by Geography

1.3.5 Analysis Period

1.3.6 Market Data Reporting Unit

1.3.6.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

3.1 Voice of Industry Experts/KOLs

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Product

4.1.1.1 Guidance systems

4.1.1.2 Biopsy needles/guns

4.1.1.3 Biopsy tables

4.1.1.4 Biopsy wires

4.1.1.5 Others

4.1.2 By Procedure Type

4.1.2.1 Vacuum-assisted biopsy

4.1.2.2 Core needle biopsy

4.1.2.3 Fine needle aspiration biopsy

4.1.2.4 Surgical biopsy

4.1.3 By Imaging Modality

4.1.3.1 Mammography guided stereotactic biopsy

4.1.3.2 Ultrasound guided biopsy

4.1.3.3 MRI guided biopsy

4.1.3.4 CT guided biopsy

4.1.3.5 Others

4.1.4 By End-User

4.1.4.1 Diagnostic centers

4.1.4.2 Hospitals

4.1.4.3 Others

4.2 Market Dynamics

4.2.1 Trend

4.2.1.1 Emergence of liquid biopsy

4.2.2 Drivers

4.2.2.1 Increasing incidence of breast cancer

4.2.2.2 Rising number of breast cancer screening programs

4.2.2.3 Technological advancements in breast imaging equipment

4.2.2.4 Increasing demand for minimally invasive surgeries

4.2.2.5 Aging women population

4.2.2.6 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 Regulatory issues and product recalls

4.2.3.2 Side effects related to post breast biopsy procedures

4.2.3.3 High procedure costs

4.2.3.4 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Untapped emerging economies

4.2.4.2 Increasing awareness regarding breast cancer

4.3 Porter’s Five Forces Analysis

4.3.1 Bargaining Power of Buyers

4.3.2 Bargaining Power of Suppliers

4.3.3 Intensity of Rivalry

4.3.4 Threat of New Entrants

4.3.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast

5.1 By Product

5.2 By Procedure Type

5.3 By Imaging Modality

5.4 By End-User

5.5 By Region

Chapter 6. North America Market Size and Forecast

6.1 By Product

6.2 By Procedure Type

6.3 By Imaging Modality

6.4 By End-User

6.5 By Country

Chapter 7. Europe Market Size and Forecast

7.1 By Product

7.2 By Procedure Type

7.3 By Imaging Modality

7.4 By End-User

7.5 By Country

Chapter 8. APAC Market Size and Forecast

8.1 By Product

8.2 By Procedure Type

8.3 By Imaging Modality

8.4 By End-User

8.5 By Country

Chapter 9. RoW Market Size and Forecast

9.1 By Product

9.2 By Procedure Type

9.3 By Imaging Modality

9.4 By End-User

9.5 By Country

Chapter 10. Competitive Landscape

10.1 Product Benchmarking of Key Players

10.2 Global Strategic Developments of Key Players

Chapter 11. Company Profiles

11.1 Hologic Inc.

11.1.1 Business Overview

11.1.2 Product and Service Offerings

11.1.3 Key Financial Summary

11.1.4 Strategic Growth Plans

11.2 Danaher Corporation

11.2.1 Business Overview

11.2.2 Product and Service Offerings

11.2.3 Key Financial Summary

11.2.4 Strategic Growth Plans

11.3 Argon Medical Devices Inc.

11.3.1 Business Overview

11.3.2 Product and Service Offerings

11.3.3 Strategic Growth Plans

11.4 Becton, Dickinson and Company

11.4.1 Business Overview

11.4.2 Product and Service Offerings

11.4.3 Key Financial Summary

11.4.4 Strategic Growth Plans

11.5 Sterylab S.R.L.

11.5.1 Business Overview

11.5.2 Product and Service Offerings

11.6 Scion Medical Technologies LLC

11.6.1 Business Overview

11.6.2 Product and Service Offerings

11.7 Planmed Oy

11.7.1 Business Overview

11.7.2 Product and Service Offerings

11.8 Siemens AG

11.8.1 Business Overview

11.8.2 Product and Service Offerings

11.8.3 Key Financial Summary

11.8.4 Strategic Growth Plans

11.9 Medtronic plc

11.9.1 Business Overview

11.9.2 Product and Service Offerings

11.9.3 Key Financial Summary

11.9.4 Strategic Growth Plans

11.1 Cook Medical LLC

11.10.1 Business Overview

11.10.2 Product and Service Offerings

Chapter 12. Appendix

12.1 Abbreviations

12.2 Sources and References

12.3 Related Reports

LIST OF TABLES

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 GLOBAL BREAST BIOPSY DEVICES MARKET, BY PRODUCT, $M (2013–2017)

TABLE 5 GLOBAL BREAST BIOPSY DEVICES MARKET, BY PRODUCT, $M (2018–2023)

TABLE 6 GLOBAL BREAST BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, $M (2013–2017)

TABLE 7 GLOBAL BREAST BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, $M (2018–2023)

TABLE 8 GLOBAL BREAST BIOPSY DEVICES MARKET, BY IMAGING MODALITY, $M (2013–2017)

TABLE 9 GLOBAL BREAST BIOPSY DEVICES MARKET, BY IMAGING MODALITY, $M (2018–2023)

TABLE 10 GLOBAL BREAST BIOPSY DEVICES MARKET, BY END-USER, $M (2013–2017)

TABLE 11 GLOBAL BREAST BIOPSY DEVICES MARKET, BY END-USER, $M (2018–2023)

TABLE 12 GLOBAL BREAST BIOPSY DEVICES MARKET, BY REGION, $M (2013–2017)

TABLE 13 GLOBAL BREAST BIOPSY DEVICES MARKET, BY REGION, $M (2018–2023)

TABLE 14 ESTIMATED NEW FEMALE BREAST CANCER CASES AND DEATHS IN THE U.S. (2015)

TABLE 15 NORTH AMERICA BREAST BIOPSY DEVICES MARKET, BY PRODUCT, $M (2013–2017)

TABLE 16 NORTH AMERICA BREAST BIOPSY DEVICES MARKET, BY PRODUCT, $M (2018–2023)

TABLE 17 NORTH AMERICA BREAST BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, $M (2013–2017)

TABLE 18 NORTH AMERICA BREAST BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, $M (2018–2023)

TABLE 19 NORTH AMERICA BREAST BIOPSY DEVICES MARKET, BY IMAGING MODALITY, $M (2013–2017)

TABLE 20 NORTH AMERICA BREAST BIOPSY DEVICES MARKET, BY IMAGING MODALITY, $M (2018–2023)

TABLE 21 NORTH AMERICA BREAST BIOPSY DEVICES MARKET, BY END-USER, $M (2013–2017)

TABLE 22 NORTH AMERICA BREAST BIOPSY DEVICES MARKET, BY END-USER, $M (2018–2023)

TABLE 23 NORTH AMERICA BREAST BIOPSY DEVICES MARKET, BY COUNTRY, $M (2013–2017)

TABLE 24 NORTH AMERICA BREAST BIOPSY DEVICES MARKET, BY COUNTRY, $M (2018–2023)

TABLE 25 EUROPE BREAST BIOPSY DEVICES MARKET, BY PRODUCT, $M (2013–2017)

TABLE 26 EUROPE BREAST BIOPSY DEVICES MARKET, BY PRODUCT, $M (2018–2023)

TABLE 27 EUROPE BREAST BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, $M (2013–2017)

TABLE 28 EUROPE BREAST BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, $M (2018–2023)

TABLE 29 EUROPE BREAST BIOPSY DEVICES MARKET, BY IMAGING MODALITY, $M (2013–2017)

TABLE 30 EUROPE BREAST BIOPSY DEVICES MARKET, BY IMAGING MODALITY, $M (2018–2023)

TABLE 31 EUROPE BREAST BIOPSY DEVICES MARKET, BY END-USER, $M (2013–2017)

TABLE 32 EUROPE BREAST BIOPSY DEVICES MARKET, BY END-USER, $M (2018–2023)

TABLE 33 EUROPE BREAST BIOPSY DEVICES MARKET, BY COUNTRY, $M (2013–2017)

TABLE 34 EUROPE BREAST BIOPSY DEVICES MARKET, BY COUNTRY, $M (2018–2023)

TABLE 35 APAC BREAST BIOPSY DEVICES MARKET, BY PRODUCT, $M (2013–2017)

TABLE 36 APAC BREAST BIOPSY DEVICES MARKET, BY PRODUCT, $M (2018–2023)

TABLE 37 APAC BREAST BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, $M (2013–2017)

TABLE 38 APAC BREAST BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, $M (2018–2023)

TABLE 39 APAC BREAST BIOPSY DEVICES MARKET, BY IMAGING MODALITY, $M (2013–2017)

TABLE 40 APAC BREAST BIOPSY DEVICES MARKET, BY IMAGING MODALITY, $M (2018–2023)

TABLE 41 APAC BREAST BIOPSY DEVICES MARKET, BY END-USER, $M (2013–2017)

TABLE 42 APAC BREAST BIOPSY DEVICES MARKET, BY END-USER, $M (2018–2023)

TABLE 43 APAC BREAST BIOPSY DEVICES MARKET, BY COUNTRY, $M (2013–2017)

TABLE 44 APAC BREAST BIOPSY DEVICES MARKET, BY COUNTRY, $M (2018–2023)

TABLE 45 ROW BREAST BIOPSY DEVICES MARKET, BY PRODUCT, $M (2013–2017)

TABLE 46 ROW BREAST BIOPSY DEVICES MARKET, BY PRODUCT, $M (2018–2023)

TABLE 47 ROW BREAST BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, $M (2013–2017)

TABLE 48 ROW BREAST BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, $M (2018–2023)

TABLE 49 ROW BREAST BIOPSY DEVICES MARKET, BY IMAGING MODALITY, $M (2013–2017)

TABLE 50 ROW BREAST BIOPSY DEVICES MARKET, BY IMAGING MODALITY, $M (2018–2023)

TABLE 51 ROW BREAST BIOPSY DEVICES MARKET, BY END-USER, $M (2013–2017)

TABLE 52 ROW BREAST BIOPSY DEVICES MARKET, BY END-USER, $M (2018–2023)

TABLE 53 ROW BREAST BIOPSY DEVICES MARKET, BY COUNTRY, $M (2013–2017)

TABLE 54 ROW BREAST BIOPSY DEVICES MARKET, BY COUNTRY, $M (2018–2023)

TABLE 55 HOLOGIC INC. – AT A GLANCE

TABLE 56 HOLOGIC INC. – KEY FINANCIAL SUMMARY

TABLE 57 DANAHER CORPORATION – AT A GLANCE

TABLE 58 DANAHER CORPORATION – KEY FINANCIAL SUMMARY

TABLE 59 ARGON MEDICAL DEVICES INC. – AT A GLANCE

TABLE 60 BECTON, DICKINSON AND COMPANY – AT A GLANCE

TABLE 61 BECTON, DICKINSON AND COMPANY – KEY FINANCIAL SUMMARY

TABLE 62 STERYLAB S.R.L. – AT A GLANCE

TABLE 63 SCION MEDICAL TECHNOLOGIES LLC – AT A GLANCE

TABLE 64 PLANMED OY – AT A GLANCE

TABLE 65 SIEMENS AG – AT A GLANCE

TABLE 66 SIEMENS AG – KEY FINANCIAL SUMMARY

TABLE 67 MEDTRONIC PLC – AT A GLANCE

TABLE 68 MEDTRONIC PLC – KEY FINANCIAL SUMMARY

TABLE 69 COOK MEDICAL LLC – AT A GLANCE

LIST OF FIGURES

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 GLOBAL BREAST BIOPSY DEVICES MARKET SUMMARY

FIG 9 OPINION OF INDUSTRY EXPERTS/KOLS

FIG 10 PORTER’S FIVE FORCES ANALYSIS

FIG 11 GLOBAL BREAST BIOPSY DEVICES MARKET SPLIT, BY PRODUCT (2017)

FIG 12 GLOBAL BREAST BIOPSY DEVICES MARKET, BY PRODUCT, $M (2013–2023)

FIG 13 GLOBAL BREAST BIOPSY DEVICES MARKET SPLIT, BY PROCEDURE TYPE (2017)

FIG 14 GLOBAL BREAST BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, $M (2013–2023)

FIG 15 GLOBAL BREAST BIOPSY DEVICES MARKET SPLIT, BY IMAGING MODALITY (2017)

FIG 16 GLOBAL BREAST BIOPSY DEVICES MARKET, BY IMAGING MODALITY, $M (2013–2023)

FIG 17 GLOBAL BREAST BIOPSY DEVICES MARKET SPLIT, BY END-USER (2017)

FIG 18 GLOBAL BREAST BIOPSY DEVICES MARKET, BY END-USER, $M (2013–2023)

FIG 19 WORLDWIDE MAJOR MARKETS FOR BREAST BIOPSY DEVICES

FIG 20 NORTH AMERICA BREAST BIOPSY DEVICES MARKET SNAPSHOT

FIG 21 NORTH AMERICA BREAST BIOPSY DEVICES MARKET, BY PRODUCT, $M (2013–2023)

FIG 22 NORTH AMERICA BREAST BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, $M (2013–2023)

FIG 23 NORTH AMERICA BREAST BIOPSY DEVICES MARKET, BY IMAGING MODALITY, $M (2013–2023)

FIG 24 NORTH AMERICA BREAST BIOPSY DEVICES MARKET, BY END-USER, $M (2013–2023)

FIG 25 NORTH AMERICA BREAST BIOPSY DEVICES MARKET, BY COUNTRY, $M (2013–2023)

FIG 26 EUROPE BREAST BIOPSY DEVICES MARKET SNAPSHOT

FIG 27 EUROPE BREAST BIOPSY DEVICES MARKET, BY PRODUCT, $M (2013–2023)

FIG 28 EUROPE BREAST BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, $M (2013–2023)

FIG 29 EUROPE BREAST BIOPSY DEVICES MARKET, BY IMAGING MODALITY, $M (2013–2023)

FIG 30 EUROPE BREAST BIOPSY DEVICES MARKET, BY END-USER, $M (2013–2023)

FIG 31 EUROPE BREAST BIOPSY DEVICES MARKET, BY COUNTRY, $M (2013–2023)

FIG 32 APAC BREAST BIOPSY DEVICES MARKET SNAPSHOT

FIG 33 APAC BREAST BIOPSY DEVICES MARKET, BY PRODUCT, $M (2013–2023)

FIG 34 APAC BREAST BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, $M (2013–2023)

FIG 35 APAC BREAST BIOPSY DEVICES MARKET, BY IMAGING MODALITY, $M (2013–2023)

FIG 36 APAC BREAST BIOPSY DEVICES MARKET, BY END-USER, $M (2013–2023)

FIG 37 APAC BREAST BIOPSY DEVICES MARKET, BY COUNTRY, $M (2013–2023)

FIG 38 ROW BREAST BIOPSY DEVICES MARKET SNAPSHOT

FIG 39 ROW BREAST BIOPSY DEVICES MARKET, BY PRODUCT, $M (2013–2023)

FIG 40 ROW BREAST BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, $M (2013–2023)

FIG 41 ROW BREAST BIOPSY DEVICES MARKET, BY IMAGING MODALITY, $M (2013–2023)

FIG 42 ROW BREAST BIOPSY DEVICES MARKET, BY END-USER, $M (2013–2023)

FIG 43 ROW BREAST BIOPSY DEVICES MARKET, BY COUNTRY, $M (2013–2023)

FIG 44 PRODUCT BENCHMARKING OF KEY PLAYERS

FIG 45 HOLOGIC INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)

FIG 46 DANAHER CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2016)

FIG 47 BECTON, DICKINSON AND COMPANY – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)

FIG 48 SIEMENS AG – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)

FIG 49 MEDTRONIC PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)



【レポートのキーワード】

乳房組織生検装置

★調査レポート[乳房組織生検装置の世界市場規模・シェア・開発・成長・需要予測] (コード:PSM804029)販売に関する免責事項を必ずご確認ください。
★調査レポート[乳房組織生検装置の世界市場規模・シェア・開発・成長・需要予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆